SCHEDULE 13G/A: Tasso Partners and Dana Carrera Update Beneficial Ownership in DarioHealth Corp. to 6.85% and 7.94% Respectively

Tasso Partners, LLC and Dana Carrera have filed an amended Schedule 13G, disclosing their updated beneficial ownership stakes in DarioHealth Corp. common stock as of March 31, 2025.

Summary

• Tasso Partners, LLC and Dana Carrera have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership of DarioHealth Corp. Common Stock.
• As of March 31, 2025, Tasso Partners, LLC beneficially owns an aggregate of 3,009,043 shares of DarioHealth Corp. common stock, representing 6.85% of the class.
• Tasso Partners, LLC's ownership includes 1,762,907 shares of common stock, 1,222,772 shares of common stock convertible from Preferred C Stock, and 23,364 shares of common stock convertible from Preferred C-2 Stock.
• Dana Carrera beneficially owns an aggregate of 3,519,043 shares of DarioHealth Corp. common stock, representing 7.94% of the class.
• Dana Carrera's beneficial ownership includes 1,887,907 shares of Common Stock held by the Reporting Person (which includes 125,000 shares owned by the GCL Family Trust), 1,222,772 shares of common stock convertible from Preferred C Stock, 23,364 shares of common stock convertible from Preferred C-2 Stock, and warrants to purchase 385,000 shares of common stock owned by the GCL Family Trust.
• Both reporting persons disclaim that the securities were acquired or are held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing disclosing beneficial ownership, which is neutral in sentiment. It provides factual information without indicating positive or negative operational or financial performance.

Future Outlook

NA

Management Comments

• The Reporting Persons certify that, to the best of their knowledge and belief, the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a standard regulatory disclosure of beneficial ownership and does not provide specific insights into broader industry trends or competitive positioning for DarioHealth Corp. It indicates continued investment by Tasso Partners, LLC and Dana Carrera in the digital health sector.

Stakeholder Impact

• This filing primarily impacts shareholders by providing transparency on significant ownership stakes.
• It confirms that a key investor group maintains a substantial position in DarioHealth Corp. without intending to influence control.

Key Dates

Keywords

DarioHealth Corp., DRX, Schedule 13G/A, Beneficial Ownership, Tasso Partners LLC, Dana Carrera, Common Stock, Preferred Stock, Warrants, SEC Filing, Investment, Shareholder